According to a research report “ENT Devices Market (By Product: Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, and Nasal Splints; By End User: Hospitals, Clinics, Ambulatory Settings, & others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030″ published by Precedence Research, the ENT devices market is projected to grow from USD 21.5 billion in 2021 and is forecasted to reach USD 30.5 billion by 2030; it is expected to grow at a CAGR of 5 % from 2021 to 2030.
The study provides an analysis of the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2021 is considered as the base year.
The factors which spur the growth of the market are raising geriatric population, increasing prevalence of ENT-related disorders, increasing penetration of minimally invasive ENT procedures. Moreover, technological advancement in the devices such as robot-assisted endoscopes systems leads to enhance the growth of the market.
Get a Free Sample Copy of this Report with Global Industry Analysis @ https://www.precedenceresearch.com/sample/1396
Moreover, ENT devices is registering it mark in the hospital, and clinics, as the increased in spending on healthcare facilities by government and private hospitals and rise in per capita are likely to augment the growth of the market.
The factors which augment the market are increasing prevalence of ear, nose, and throat related disorders. According to the data by World Health Organization in 2018, in United States, the incidence of hearing loss has increased from 11.5 million in 2008, to nearly 15 million in 2018.The ENT devices is expected to change the way the hospitals and clinics by introducing innovative methods and insights.
Table of Contents
Scope of the ENT Devices Market Report
Report Highlights | Details |
Market Size | USD 30.5 Billion by 2030 |
Growth Rate | CAGR of 5% From 2021 to 2030 |
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2021 |
Forecast Period | 2021 to 2030 |
Segments Covered | Product, End User, Region |
Report Highlights
- Based on the product, the diagnostic devices segment accounted largest revenue share 29% in 2020. This can be attributed to increase in geriatric population along with rising prevalence of various ear, nose, and throat (ENT) disorders.
- The hearing aids segment is expected to grow at the fastest rate over the forecast period due to increasing adoption of these devices, and technological advancements due to an increase in investment by market players on R&D.
- Based on the end user, the hospitals segment was the leading segment in 2020. The rising prevalence of diseases coupled with the increased number of hospital admissions has significantly contributed towards the growth of this segment in the past few years. Moreover, rising investments for the development of better and improve healthcare infrastructure is boosting the growth of the hospitals especially in the developing regions.
Future of ENT Devices Market
The disorders related to ear, throat, and nose is rising at a rapid pace. This is resulting for the surge in demand for ENT devices in the market. In addition, the growing awareness of ENT devices among patients and healthcare practitioners is driving the global ENT devices market. Moreover, the growing geriatric population is creating lucrative opportunities for the expansion of the global ENT devices market.
The old age people are more prone to ear, nose, and throat disorders, which increase need for installation of ENT devices in the healthcare centers and hospitals. Furthermore, the rising penetration of innovative technologies and innovation in the medical devices industry is paving way for the growth of the global ENT devices market. In addition, the strict government rules and guidelines in developed and developing regions is also driving the ENT devices market expansion. As a result, due to all of these factors, the market for ENT devices is expected to grow in the near future.
COVID-19 Impact Analysis:
- The growth of the global ENT devices market was declining during the COVID-19 pandemic.
- The hospitals visit for the treatment of ear, nose, and throat related disorders declined during the coronavirus outbreak.
- In addition, the supply chain disruption also caused negative impact on the global ENT devices market.
- However, the market for ENT devices is expected to rebound in coming years due to the removal of lockdown restrictions.
Key Developments in the Marketplace:
- WIDEX MOMENT, the first generation of hearing aids that sound natural was launched by WS Audiology in March 2020. Widex’s unique ZeroDelay Technology makes this possible.
- In 2020, Sonova Holding AG will open World of Hearing, a new retail format in the field of hearing solutions in the Netherlands to grow its ENT devices research and commercial manufacture. Sonova Holding AG introduced innovative technology that allows hearing aid fits to be done completely remotely.
- GN Hearing and Cochlear Limited teamed up with Google in September 2019 to declare support for direct streaming from Android devices to hearing equipment through Bluetooth Low Energy.
Regional Scope
North America dominated the market and garnered 36% revenue share in 2020. This is attributed to the increased adoption rate of the latest technologies in the countries like US and Canada. The presence of high number of market players. The major factors which gain a major demand for the ENT devices are better healthcare infrastructure, favorable reimbursement policies, high cases of chronic sinusitis, and other ENT disorders.
Europe region accounted for the second-largest revenue share in 2020. The region has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels.
Asia Pacific is expected to be the most opportunistic market during the forecast period. The rising government expenditure to develop strong healthcare infrastructure and government policies to attract FDIs is expected to play a significant role in the growth of the ENT devices market in the region. The presence of huge population and rising number of hospital admissions will foster the demand for the ENT devices in the Asia Pacific region, and will lead to the growth of the market during the forecast period.
The rising prevalence of ear, nose, and throat related disorders among the population will boost the demand for the ENT devices. Moreover, the rising adoption of minimally invasive ENT procedures and technological advancements are the driving factors for the growth of the market.
The high instrument costs and procedure associated with the and capital in the underdeveloped and developing nations may hamper the market growth during the forecast period.
The introduction of latest technologies such as artificial intelligence and machine learning may provide growth prospects to the market players in the upcoming future, and drive the market growth.
Read Also: Digital Health Market Size to Gain US$ 551 Billion by 2027
Some of the prominent players in the global ENT Devices market include:
- Demant A/S
- Sonova
- Ambu A/S
- Pentax Medical
- Karl Storz
- Olympus Corporation
- Richard Wolf Gmbh
- Widex
- Cochlear Ltd.
- Sivantos, Inc.
Segments Covered in the Report
By Product
- Diagnostic ENT Devices
- Surgical ENT Devices
- Hearing Aids
- Hearing Implants
- Nasal Splints
By End User
- Hospitals
- Ambulatory settings
- ENT clinics
- Research and academic institutes
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
Why should you invest in this report?
If you are aiming to enter the global ENT devices market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for ENT devices are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on ENT Devices Market
5.1. COVID-19 Landscape: ENT Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global ENT Devices Market, By Product
8.1. ENT Devices Market, by Product Type, 2021-2030
8.1.1. Diagnostic ENT Devices
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Surgical ENT Devices
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Hearing Aids
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Hearing Implants
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global ENT Devices Market, By Application
9.1. ENT Devices Market, by Application, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Ambulatory settings
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. ENT clinics
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Research and academic institutes
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global ENT Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
Chapter 11. Company Profiles
11.1. Demant A/S
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Sonova
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Ambu A/S
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pentax Medical
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Karl Storz
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Olympus Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Richard Wolf Gmbh
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Widex
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Cochlear Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Sivantos, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1396
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com